Understanding Alpha-1 With The National Jewish Medical and Research Center
November 5, 2013
Alpha-1 isn’t a rare disease, just rarely diagnosed
Lifetime Television’s “The Balancing Act” welcomes Dr. Robert Sandhaus from the National Jewish Medical and Research Center as he talks about Alpha-1 (Antitrypsin Deficiency), explaining why this disease is so often misdiagnosed. Alpha-1 Testing is now more readily available; thanks to CSL Behring’s wider range of testing resources.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.